Senator Win Gatchalian backs the progressive expansion of limited face-to-face classes in areas under Alert Levels 1 and 2, calling the move a crucial next step in the recovery of the basic education sector from the impact of the COVID-19 pandemic.

In rolling out a learning recovery program to address learning loss amid the COVID-19 pandemic, Senator Win Gatchalian is proposing tapping college students as tutors.

The CCF Life Academy Foundation, Inc. is now officially recognized as an educational institution of international character with the signing of Republic Act No. 11638. Senator Win Gatchalian, sponsor and co-author of the measure, says the law expands opportunities for Filipino learners and their families to access international education.

Senator Win Gatchalian hailed the signing of a law that would grant tax relief to private schools, a move that the lawmaker said would help them stay afloat amid the devastating effects of the COVID-19 pandemic.

Following the Department of Finance’s (DOF) warning of an economic scarring because of a prolonged lack of face-to-face classes, Senator Win Gatchalian is pitching a nationwide remedial program to accelerate learning recovery.

Senator Win Gatchalian is urging local government units (LGUs) to prepare for the vaccination of children aged 5 to 11, a move that he said would be crucial in boosting confidence in safely reopening schools amid the threat of the Omicron variant.

Senator Win Gatchalian is urging the Department of Education (DepEd), Department of Health (DOH), and Department of Social Welfare and Development (DSWD) to uphold the safety and welfare of children in Odette-hit areas.

While Senator Win Gatchalian welcomed the addition of more schools in the pilot implementation of limited face-to-face classes, he pressed the need for continued vigilance especially as the world monitors the threat of the Omicron variant.

Senator Win Gatchalian is pressing to accelerate the vaccination of minors and teachers following the global alarm on the COVID-19 variant Omicron.